Topoisomerase I inhibitors in the treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia
- PMID: 15068895
- DOI: 10.1016/j.leukres.2003.10.010
Topoisomerase I inhibitors in the treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia
Comment on
-
Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study.Leuk Res. 2004 Jan;28(1):49-52. doi: 10.1016/s0145-2126(03)00181-4. Leuk Res. 2004. PMID: 14630080 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical